GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: ABT-267 | ABT267 | compound 38 [PMID: 24400777] | Technivie® (ombitasvir  + paritaprevir  + ritonavir) | Viekirax® (ombitasvir + paritaprevir + ritonavir; EU)
                                 ombitasvir is an approved drug (FDA (2015), EMA (2020)) Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Ombitasvir is an orally available, direct-acting inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex [1]. In common with many other NS5A inhibitors it is a dinucleotide derivative.
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Bioactivity Comments | 
| ABT-267 exhibits pan-genotypic anti-HCV activity, with an EC50 range of 1.7-19.3 pM against GT1a, -1b, -2a, -2b, -3a, -4a, and -5a and 366 pM against GT6a [1]. |